Literature DB >> 32693800

Processes of consent in research for adults with impaired mental capacity nearing the end of life: systematic review and transparent expert consultation (MORECare_Capacity statement).

C J Evans1,2, E Yorganci3, P Lewis4, J Koffman3, K Stone3, I Tunnard3, B Wee5, W Bernal6, M Hotopf7, I J Higginson3.   

Abstract

BACKGROUND: Involving adults lacking capacity (ALC) in research on end of life care (EoLC) or serious illness is important, but often omitted. We aimed to develop evidence-based guidance on how best to include individuals with impaired capacity nearing the end of life in research, by identifying the challenges and solutions for processes of consent across the capacity spectrum.
METHODS: Methods Of Researching End of Life Care_Capacity (MORECare_C) furthers the MORECare statement on research evaluating EoLC. We used simultaneous methods of systematic review and transparent expert consultation (TEC). The systematic review involved four electronic databases searches. The eligibility criteria identified studies involving adults with serious illness and impaired capacity, and methods for recruitment in research, implementing the research methods, and exploring public attitudes. The TEC involved stakeholder consultation to discuss and generate recommendations, and a Delphi survey and an expert 'think-tank' to explore consensus. We narratively synthesised the literature mapping processes of consent with recruitment outcomes, solutions, and challenges. We explored recommendation consensus using descriptive statistics. Synthesis of all the findings informed the guidance statement.
RESULTS: Of the 5539 articles identified, 91 met eligibility. The studies encompassed people with dementia (27%) and in palliative care (18%). Seventy-five percent used observational designs. Studies on research methods (37 studies) focused on processes of proxy decision-making, advance consent, and deferred consent. Studies implementing research methods (30 studies) demonstrated the role of family members as both proxy decision-makers and supporting decision-making for the person with impaired capacity. The TEC involved 43 participants who generated 29 recommendations, with consensus that indicated. Key areas were the timeliness of the consent process and maximising an individual's decisional capacity. The think-tank (n = 19) refined equivocal recommendations including supporting proxy decision-makers, training practitioners, and incorporating legislative frameworks.
CONCLUSIONS: The MORECare_C statement details 20 solutions to recruit ALC nearing the EoL in research. The statement provides much needed guidance to enrol individuals with serious illness in research. Key is involving family members early and designing study procedures to accommodate variable and changeable levels of capacity. The statement demonstrates the ethical imperative and processes of recruiting adults across the capacity spectrum in varying populations and settings.

Entities:  

Keywords:  Consensus; Consent; Decision-making; Ethics; Methods; Palliative care; Systematic review; Terminal care

Mesh:

Year:  2020        PMID: 32693800      PMCID: PMC7374835          DOI: 10.1186/s12916-020-01654-2

Source DB:  PubMed          Journal:  BMC Med        ISSN: 1741-7015            Impact factor:   8.775


  116 in total

1.  Surrogate consent for dementia research: factors influencing five stakeholder groups from the SCORES study.

Authors:  Gina Bravo; Scott Y H Kim; Marie-France Dubois; Carole A Cohen; Sheila M Wildeman; Janice E Graham
Journal:  IRB       Date:  2013 Jul-Aug

2.  How do patients feel about taking part in clinical trials in emergency care?

Authors:  Joseph M Buckley; Andy D Irving; Steve Goodacre
Journal:  Emerg Med J       Date:  2016-01-12       Impact factor: 2.740

3.  Advanced dementia research in the nursing home: the CASCADE study.

Authors:  Susan L Mitchell; Dan K Kiely; Richard N Jones; Holly Prigerson; Ladislav Volicer; Joan M Teno
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jul-Sep       Impact factor: 2.703

4.  Multimedia Aided Consent for Alzheimer's Disease Research.

Authors:  Barton W Palmer; Alexandrea L Harmell; Laura B Dunn; Scott Y Kim; Luz L Pinto; Shahrokh Golshan; Dilip V Jeste
Journal:  Clin Gerontol       Date:  2017-11-28       Impact factor: 2.619

5.  Design of trials with dying patients: a feasibility study of cluster randomisation versus randomised consent.

Authors:  A Fowell; R Johnstone; I G Finlay; D Russell; I T Russell
Journal:  Palliat Med       Date:  2006-12       Impact factor: 4.762

6.  Effect of public deliberation on attitudes toward surrogate consent for dementia research.

Authors:  S Y H Kim; H M Kim; D S Knopman; R De Vries; L Damschroder; P S Appelbaum
Journal:  Neurology       Date:  2011-10-05       Impact factor: 9.910

7.  Enhancing the informed consent process for critical care research: strategies from a thromboprophylaxis trial.

Authors:  Orla M Smith; Ellen McDonald; Nicole Zytaruk; Denise Foster; Andrea Matte; France Clarke; Suzie Fleury; Katie Krause; Tracey McArdle; Yoanna Skrobik; Deborah J Cook
Journal:  Intensive Crit Care Nurs       Date:  2013-07-18       Impact factor: 3.072

Review 8.  Evidence for improving palliative care at the end of life: a systematic review.

Authors:  Karl A Lorenz; Joanne Lynn; Sydney M Dy; Lisa R Shugarman; Anne Wilkinson; Richard A Mularski; Sally C Morton; Ronda G Hughes; Lara K Hilton; Margaret Maglione; Shannon L Rhodes; Cony Rolon; Virginia C Sun; Paul G Shekelle
Journal:  Ann Intern Med       Date:  2008-01-15       Impact factor: 25.391

9.  The views of Alzheimer disease patients and their study partners on proxy consent for clinical trial enrollment.

Authors:  Jason Karlawish; Scott Y H Kim; David Knopman; Christopher H van Dyck; Bryan D James; Daniel Marson
Journal:  Am J Geriatr Psychiatry       Date:  2008-03       Impact factor: 4.105

10.  Unrecognised cognitive impairment in hospice patients: a pilot study.

Authors:  S A Irwin; C H Zurhellen; L C Diamond; L B Dunn; B W Palmer; D V Jeste; E W Twamley
Journal:  Palliat Med       Date:  2008-09-04       Impact factor: 4.762

View more
  5 in total

1.  Unpacking the 'black box of horrendousness': a qualitative exploration of the barriers and facilitators to conducting trials involving adults lacking capacity to consent.

Authors:  Victoria Shepherd; Kerenza Hood; Fiona Wood
Journal:  Trials       Date:  2022-06-06       Impact factor: 2.728

2.  Patterns of unplanned hospital admissions among people with dementia: from diagnosis to the end of life.

Authors:  Emel Yorganci; Robert Stewart; Elizabeth L Sampson; Katherine E Sleeman
Journal:  Age Ageing       Date:  2022-05-01       Impact factor: 12.782

3.  Development of a core outcome set for the evaluation of interventions to enhance trial participation decisions on behalf of adults who lack capacity to consent: a mixed methods study (COnSiDER Study).

Authors:  V Shepherd; F Wood; M Robling; E Randell; K Hood
Journal:  Trials       Date:  2021-12-19       Impact factor: 2.728

4.  Research policy in supportive care and palliative care for cancer dyspnea.

Authors:  Yoshinobu Matsuda; Takashi Yamaguchi; Yoshihisa Matsumoto; Hiroto Ishiki; Yuko Usui; Jun Kako; Kozue Suzuki; Ryo Matsunuma; Masanori Mori; Hiroaki Watanabe; Sadamoto Zenda
Journal:  Jpn J Clin Oncol       Date:  2022-03-03       Impact factor: 3.019

5.  Implementation of a complex intervention to improve care for patients whose situations are clinically uncertain in hospital settings: A multi-method study using normalisation process theory.

Authors:  Halle Johnson; Emel Yorganci; Catherine J Evans; Stephen Barclay; Fliss E M Murtagh; Deokhee Yi; Wei Gao; Elizabeth L Sampson; Joanne Droney; Morag Farquhar; Jonathan Koffman
Journal:  PLoS One       Date:  2020-09-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.